References
- Lo Monte G, Piva I, Bazzan E, Marci R, Ogrin C. Luteal phase support for assisted reproductive technologies: between past, present and future. Minerva Endocrinol. 2013;38:401.24285108
- Yanushpolsky EH. Luteal phase support in in vitro fertilization. Semin Reprod Med. 2015;33:118–127. doi:10.1055/s-0035-154536325734349
- Deichert U, Hackelöer BJ, Daume E. The sonographic and endocrinologic evaluation of the endometrium in the luteal phase. Hum Reprod. 1986;1:219. doi:10.1093/oxfordjournals.humrep.a1363883549767
- Kohls G, Ruiz F, Martínez M, et al. Early progesterone cessation after in vitro fertilization/intracytoplasmic sperm injection: a randomized, controlled trial. Fertil Steril. 2012;98:858–862. doi:10.1016/j.fertnstert.2012.05.04622749223
- Yovich JL, Stanger JD, Yovich JM, Tuvik AI, Turner SR. Hormonal profiles in the follicular phase, luteal phase and first trimester of pregnancies arising from in-vitro fertilization. Br J Obstet Gynaecol. 2010;92:374–384. doi:10.1111/j.1471-0528.1985.tb01112.x
- de Lignières B. Oral micronized progesterone. Clin Ther. 1999;21:41–60. doi:10.1016/S0149-2918(00)88267-310090424
- Schumacher M, Guennoun R, Robert F, et al. Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm IGF Res. 2004;14:18–33. doi:10.1016/j.ghir.2004.03.007
- Belelli D, Lambert JJ. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci. 2005;6:565–575. doi:10.1038/nrn170315959466
- Harrison NL, Majewska MD, Harrington JW, Barker JL. Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex. J Pharmacol Exp Ther. 1987;241:346.3033209
- Stute P, Neulen J, Wildt L. The impact of micronized progesterone on the endometrium: a systematic review. Climacteric. 2016;19:316–328. doi:10.1080/13697137.2016.118712327277331
- Probst AM, Hill JA, Ginsburg ES, Hurwitz S, Politch J, Yanushpolsky EH. A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles. Fertil Steril. 2001;76:1144–1149.11730742
- Simunic V, Tomic V, Tomic J, Nizic D. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support. Fertil Steril. 2007;87:83–87.17081536
- Bergh C, Lindenberg S, Nordic Crinone Study Group. A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection. Hum Reprod. 2012;27:3467–3473. doi:10.1093/humrep/des34123019296
- Sofuoglu K, Gun I, Sahin S, Ozden O, Tosun O, Eroglu M. Vaginal micronized progesterone capsule versus vaginal progesterone gel for lutheal support in normoresponder IVF/ICSI-ET cycles. Pak J Med Sci. 2015;31:314.26101482
- Michnova L, Dostal J, Kudela M, Hamal P, Langova K. Vaginal use of micronized progesterone for luteal support.A randomized study comparing Utrogestan® and Crinone® 8. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017;161:86–91. doi:10.5507/bp.2017.00728323291
- Child T, Leonard SA, Evans JS, Lass A. Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles. Reprod Biomed Online. 2018;36:630–645. doi:10.1016/j.rbmo.2018.02.00129550390